Manulife (Manufacturers Life Insurance)’s BioAtla BCAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-268
Closed -$46.1K 2974
2024
Q1
$46.1K Buy
+268
New +$33.3K ﹤0.01% 2890
2023
Q4
Sell
-226
Closed -$19.2K 2963
2023
Q3
$19.2K Sell
226
-162
-42% -$20.6K ﹤0.01% 2966
2023
Q2
$58.2K Buy
+388
New +$66.7K ﹤0.01% 2944
2021
Q4
Sell
-167
Closed -$245K 3117
2021
Q3
$245K Buy
167
+27
+19% +$52.6K ﹤0.01% 2825
2021
Q2
$296K Buy
140
+13
+10% +$29.4K ﹤0.01% 2819
2021
Q1
$324K Buy
+127
New +$326K ﹤0.01% 2567

Other funds holding BCAB

Manulife (Manufacturers Life Insurance)'s BCAB Position: Q2 2024 in Review

Manulife (Manufacturers Life Insurance) sold out of BioAtla (BCAB) in Q2 2024, closing a stake of 268 shares — an estimated $46.1K sold.

Manulife (Manufacturers Life Insurance) first reported a position in BCAB in Q1 2021 and held it in 6 quarters. The position peaked at $324K in Q1 2021. 80 funds tracked by Wall St. Rank hold BCAB as of Q2 2024.

  • Manulife (Manufacturers Life Insurance) reported no remaining BioAtla position as of Q2 2024 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 268 BioAtla shares in Q2 2024, an estimated $46.1K.
  • Manulife (Manufacturers Life Insurance) first reported a position in BioAtla in Q1 2021 and held it in 6 quarters.
  • Manulife (Manufacturers Life Insurance)'s BioAtla position peaked at $324K in Q1 2021.
  • 80 funds tracked by Wall St. Rank held BioAtla as of Q2 2024.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2024, filed 14 Aug 2024.